BioSerenity
BioSerenity is a French medtech company operating an integrated connected-EEG and tele-interpretation platform for hospitals and clinics, combining Neuronaute+ portable EEG recorders, IceCap disposable caps, AI-powered cloud analysis, and proprietary foundation models to serve neurology, sleep medicine, and cardiology diagnostics across 300+ facilities.
- Company typePrivate
- Founded2014
- HeadquartersParis, France
- Headcount251–500
- GTM typeB2B
- OfferingServices
What BioSerenity does
BioSerenity is a French medtech company founded in 2014 that operates an integrated neuroscience platform combining connected medical devices, AI-powered signal analysis, and tele-interpretation services for neurology, sleep medicine, and cardiology. The core hardware consists of the Neuronaute+ portable EEG recorder and the IceCap disposable EEG cap system (five sizes from neonate to adult, up to 72-hour continuous recording), which connect via Wi-Fi to the Bioserenity Connect cloud platform for AI pre-analysis of signal abnormalities and remote specialist interpretation. AI capability is anchored by proprietary foundation models: the BIOSerenity-E1 self-supervised EEG model (arXiv, March 2025) and a multimodal sleep foundation model trained on 500,000+ hours of recordings (Nature Medicine, 2026) capable of predicting Parkinson's and breast cancer from sleep signals.
BioSerenity monetizes through three streams: sale of Neuronaute+ and IceCap devices to hospitals and clinics (hardware sales), 24/7 tele-interpretation services branded NeuroPhy (EEG), Somnophy (polysomnography), and Cardiophy (Holter ECG) delivered by a network of specialist physicians and technicians (professional services), and operation of dedicated sleep diagnostic centers inside customer healthcare facilities (managed services). Pricing is not publicly disclosed and is contracted on a B2B basis with healthcare providers. The company serves over 300 clinics and hospitals and a referral network of 9,000+ physicians, treating 150,000+ patients per year and performing 49,000+ EEGs in 2025.
The company holds FDA 510(k) clearances (four Class II devices), EU MDR Class IIa CE marking, ISO 13485:2016, and MDSAP certification covering US, Canada, Brazil, Japan, and Australia. Jolt Capital invested €24 million in November 2023 to fund US and broader European expansion and AI deployment, joining existing investors Bpifrance, Dassault Systemes, Idinvest Partners, LBO France, Kurma Partners, Scor, and Innovation Capital. Headquartered in Paris (relocated January 1, 2025), BioSerenity employs 251-500 people and operates with Emmanuel Mougeotte as CEO.
BioSerenity firmographics
Firmographics- Name
- BioSerenity
- Legal name
- BioSerenity Medical Devices Group
- Website
- https://bioserenity.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- BioSerenity is a French medtech company operating an integrated connected-EEG and tele-interpretation platform for hospitals and clinics, combining Neuronaute+ portable EEG recorders, IceCap disposable caps, AI-powered cloud analysis, and proprietary foundation models to serve neurology, sleep medicine, and cardiology diagnostics across 300+ facilities.
- Ownership category
- akta.pro rank
BioSerenity industry classification
Industry- Product category
- Neurological Diagnostic Services
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Neurology Telemedicine Platforms (HLALAGAC), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)
Keywords
Where BioSerenity is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
BioSerenity business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Others
Revenue model
- Medical Devices (Neuronaute+, IceCap): Sale and supply of connected EEG medical devices (Neuronaute+ portable EEG recorder and IceCap disposable EEG caps) to hospitals, clinics, and healthcare facilities. Devices are FDA and CE certified.
- Tele-Interpretation Services (NeuroPhy, Somnophy, Cardiophy): Remote diagnostic interpretation services for EEG (NeuroPhy), polysomnography (Somnophy), and ECG/Holter (Cardiophy). Services include on-demand realization and tele-interpretation by specialist doctors, available 24/7.
- Remote Diagnostic Centers: BioSerenity implements sleep diagnostic centers directly within healthcare facilities, providing a comprehensive service that combines equipment, technicians, and medical interpretation.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels8 records
BioSerenity product offering
Product offeringCore offering
BioSerenity sells connected EEG medical devices (Neuronaute+ portable recorder and IceCap disposable caps) integrated with a cloud-based AI analysis platform and delivers round-the-clock tele-interpretation services for EEG, polysomnography, and Holter ECG to hospitals, clinics, and sleep medicine centers. The company combines hardware, AI software, and on-demand specialist physician interpretation to enable brain monitoring and remote diagnostics across neurology, sleep medicine, and cardiology.
Product overview
BioSerenity is an integrated neuroscience platform comprising medical devices and telemedicine services. The core product portfolio includes Neuronaute+ (portable connected EEG recorder) and IceCap (disposable EEG caps) working together as a complete EEG system, supported by the Bioserenity Cloud platform for data storage and AI analysis. The service offerings include Neurophy (on-demand EEG tele-interpretation), Somnophy (polysomnography interpretation), and Cardiophy (Holter ECG interpretation), all delivered through a network of specialist physicians and technicians. B-Link and BLINK Mobile App are complementary accessories enabling video synchronization and mobile session configuration. The platform enhances neurological diagnostics and sleep disorder treatment through AI-powered pre-analysis of electrophysiological signals.
Differentiator
Problem solved
Functional benefit
Brands
- Neurophy: On-demand EEG realization and tele-interpretation service for hospitals and clinics.
- Somnophy
- Cardiophy
- Neuronaute+
- IceCap
- BIOSerenity Connect
- B-Link
- Neuronaute EEG Platform
Products and services
- Neuronaute+ Portable and connected EEG recorder that enables electroencephalographic examinations at the patient's bedside, at home, or in complex hospital environments (ICU, pediatrics, operating rooms). Compact, battery-powered, lightweight device with interchangeable extensions compatible with IceCap and standard EEG caps. Features AI pre-analysis to screen signal abnormalities. FDA-cleared Class II (K231366) and CE-marked Class IIa medical device.
- IceCap Extra-light disposable EEG cap (less than 10 grams) available in 5 sizes from neonate to adult, set up in 10 minutes for hospital or home exams. Supports recordings up to 72 hours. Compatible with standard touchproof EEG acquisition systems via Neuronaute Touchproof adapters. CE-marked Class I and FDA-cleared Class II medical device.
- Bioserenity Cloud (Connect) Web-based information system that receives EEG and video signals from the Neuronaute recorder and B-Link app through paired Wi-Fi connection. Enables long-term storage, signal integration, AI pre-analysis for abnormality screening, and remote analysis by specialists. Class IIa medical device.
- Neurophy On-demand EEG realization and tele-interpretation service providing 24/7 technician deployment with Neuronaute+ and IceCap equipment to hospitals, clinics, and private practices. Average tele-interpretation time under 2 hours for routine EEG (maximum 3 hours) and 30 minutes for emergencies. Over 300 partner hospitals and 950+ weekly examinations performed in 2025.
- Somnophy Remote polysomnography (PSG) interpretation platform providing realization and interpretation services for sleep studies. Network of sleep medicine physicians and technicians scoring PSG recordings from children to adults, 7 days a week, with 6-hour interpretation turnaround. 7 diagnostic sleep centers in France.
- Cardiophy Remote Holter ECG interpretation service offering ECG monitoring with up to 14-day battery life, wireless 3-lead patch, and semi-waterproof design. Includes interpretation by cardiologist/electrophysiologist team. Service available with 24/7 technical support.
- B-Link Mobile Application Android application that transforms a smartphone into a video monitoring and recording station synchronized with EEG recordings. Sends video data to Bioserenity Cloud for remote specialist analysis. Class IIa medical device accessory.
Quantifiable outcome
- 150,000+ patients treated yearly through BioSerenity's diagnostic services
- +6 more outcomes
Companies that use BioSerenity
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
BioSerenity technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature7 records
BioSerenity partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor.
- APTE AssociationminorAPTE Association is part of BioSerenity's Somnophy network of technicians holding Sleep Medicine degrees, providing pre-scoring services for polysomnography recordings.
- OpossommminorOpossomm is part of BioSerenity's Somnophy network of technicians holding Sleep Medicine degrees, providing pre-scoring services for polysomnography recordings.
- Circle of Sleep SocietyminorCircle of Sleep Society is part of BioSerenity's Somnophy network of technicians holding Sleep Medicine degrees, providing pre-scoring services for polysomnography recordings.
- Ensodata, Inc.minorBioSerenity collaborated with Ensodata to achieve a first-of-kind FDA clearance for interoperable AI analysis of PPG (photoplethysmography). Testimonial from Chris Fernandez, Executive Chairman and Chief Research Officer at Ensodata, highlights the successful collaboration.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
BioSerenity competitors and assessment
Company assessmentDirect peers
- Brain Products GmbH: Germany-based manufacturer of research- and clinical-grade EEG hardware and caps. Directly competes with Neuronaute+ and IceCap as a European EEG device specialist.
- Compumedics Limited: Australia-based manufacturer of clinical EEG, PSG, and sleep-diagnostic devices with cloud analysis software. Directly comparable to BioSerenity's hardware-plus-software stack for neurology and sleep labs worldwide.
- Ceribell Inc: AI-powered point-of-care EEG system with cloud-based interpretation for hospital and ICU use. Closest analog to BioSerenity's combination of bedside EEG hardware + cloud AI + remote specialist interpretation.
- Nox Medical: Icelandic sleep-diagnostics company offering PSG systems and cloud software for sleep labs. Closely comparable to BioSerenity's Somnophy PSG interpretation offering and overall sleep franchise.
- EnsoData: AI sleep-scoring and clinical diagnostics platform with FDA-cleared interoperable PSG analysis. BioSerenity has cited EnsoData as a collaborator on FDA-cleared PPG AI analysis — directly comparable on the AI-interpretation layer.
Broad incumbents
- Natus Medical Incorporated: Large neurology-diagnostics portfolio company offering EEG, PSG, EMG, and ICU monitoring devices globally. A broader incumbent that competes with BioSerenity's Neuronaute+ and IceCap in hospital neurology and sleep labs.
- Masimo Corporation: Large patient-monitoring company whose SedLine EEG-processed brain-monitoring product overlaps with BioSerenity's hospital EEG franchise. A broad incumbent with global hospital-channel reach.
- Koninklijke Philips N.V. Global health-tech incumbent with sleep & respiratory (Philips Respironics) and clinical patient-monitoring portfolios. Overlaps with BioSerenity's Somnophy sleep-diagnostic and Cardiophy ECG services in hospital and home settings.
Emerging players
- Wave Neuroscience: EEG-based personalized neurostimulation and brain-mapping platform. Comparable as an emerging EEG + AI + clinical-interpretation stack, though focused on therapy rather than diagnostics.
- iMediSync: AI-driven EEG diagnostic platform for early detection of neurological conditions (e.g., Alzheimer's, depression). Comparable to BioSerenity's foundation-model strategy of using EEG for disease prediction.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
BioSerenity social profiles
Digital presenceBioSerenity compliance and trust
Trust signalCompliance4 records
BioSerenity financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioSerenity leadership team
Management profileNumber of profiles
Profiles10 records
BioSerenity funding detail
Funding detailFunding overview
Funding rounds7 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioSerenity M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioSerenity
What does BioSerenity do?
BioSerenity sells connected EEG medical devices (Neuronaute+ portable recorder and IceCap disposable caps) integrated with a cloud-based AI analysis platform and delivers round-the-clock tele-interpretation services for EEG, polysomnography, and Holter ECG to hospitals, clinics, and sleep medicine centers. The company combines hardware, AI software, and on-demand specialist physician interpretation to enable brain monitoring and remote diagnostics across neurology, sleep medicine, and cardiology.
Is BioSerenity a public or private company?
BioSerenity is a private company. It is classified as private equity controlled and is currently operating.
When was BioSerenity founded?
BioSerenity was founded in 2014. It employs 251 to 500 people.
Where is BioSerenity based?
BioSerenity is headquartered in Paris, France, in the Europe region.
How does BioSerenity make money?
Three revenue lines are on record. Medical Devices (Neuronaute+, IceCap) is the primary driver. The others are tele-Interpretation Services (NeuroPhy, Somnophy, Cardiophy) and remote Diagnostic Centers.
Who are BioSerenity's main competitors?
Direct peers on record are Brain Products GmbH, Compumedics Limited, Ceribell Inc, Nox Medical and EnsoData. Broad incumbents are Natus Medical Incorporated, Masimo Corporation and Koninklijke Philips N.V.. Emerging players are Wave Neuroscience and iMediSync.
Does BioSerenity have an API?
No public API is recorded for BioSerenity.
What industry is BioSerenity in?
BioSerenity's product category is Neurological Diagnostic Services. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.